Combined PET/CT Imaging for the Early Detection of Ocular Melanoma Metastasis Compared to CT Scanning Alone

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00351728

Enrollment

174

Registered

2006-07-13

Start date

2006-06-30

Completion date

2012-08-31

Last updated

2016-07-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Choroidal Melanoma, Ocular Melanoma, Uveal Melanoma

Brief summary

Patients diagnosed with ocular melanoma consent to participate in the study. Combined PET/CT scans of the whole body are performed at baseline, three months later, and six months after that for a total of three combined scans in the first year. Subsequently, these combined scans will be performed at 6-monthly intervals for a total of two combined scans per year.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

1. Patients with a diagnosis of ocular melanoma (a pigmented malignant tumor) involving the choroid and/or ciliary body (the blood vessel layer in the back of the eye and/or the part of the eye behind the iris). 2. Patients 18 years of age or older. 3. Patients able to give informed consent.

Exclusion criteria

1. Patients who refuse to participate in the study. 2. Patients who are unable to cooperate with or cannot undergo PET/CT scanning. 3. Patients who will be moving out of the area of UCLA during the ten years of this study.

Countries

United States

Outcome results